HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow-to-Debt Ratio
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of CN¥-187.38 Million could theoretically repay 0% of its total liabilities (CN¥4.03 Billion) in one year. See HPGC Renmintongtai Pharmaceutical Corp (600829) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HPGC Renmintongtai Pharmaceutical Corp Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. For the full cash flow conversion analysis, see 600829 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year debt coverage analysis for HPGC Renmintongtai Pharmaceutical Corp. Check HPGC Renmintongtai Pharmaceutical Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥299.98 Million | CN¥4.16 Billion | ▲ +167.7% |
| 2024 | 0.03x | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.07x | CN¥332.99 Million | CN¥4.68 Billion | ▲ +6.5% |
| 2022 | 0.07x | CN¥307.33 Million | CN¥4.60 Billion | ▲ +230.5% |
| 2021 | -0.05x | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -2123.4% |
| 2020 | 0.00x | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +97.9% |
| 2019 | -0.11x | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -186.0% |
| 2018 | 0.13x | CN¥366.45 Million | CN¥2.83 Billion | ▲ +200.4% |
| 2017 | 0.04x | CN¥139.07 Million | CN¥3.23 Billion | ▲ +196.0% |
| 2016 | 0.01x | CN¥46.01 Million | CN¥3.16 Billion | ▼ -87.8% |
| 2015 | 0.12x | CN¥333.99 Million | CN¥2.81 Billion | ▼ -65.8% |
| 2014 | 0.35x | CN¥392.58 Million | CN¥1.13 Billion | ▲ +417.2% |
| 2013 | -0.11x | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -186.4% |
| 2012 | 0.13x | CN¥221.57 Million | CN¥1.75 Billion | ▲ +323.6% |
| 2011 | -0.06x | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -155.1% |
| 2010 | 0.10x | CN¥162.99 Million | CN¥1.58 Billion | ▼ -72.5% |
| 2009 | 0.37x | CN¥447.82 Million | CN¥1.20 Billion | ▲ +818.3% |
| 2008 | -0.05x | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -134.7% |
| 2007 | 0.15x | CN¥191.10 Million | CN¥1.27 Billion | ▼ -9.3% |
| 2006 | 0.17x | CN¥191.13 Million | CN¥1.16 Billion | ▼ -41.9% |
| 2005 | 0.28x | CN¥313.04 Million | CN¥1.10 Billion | ▲ +288.0% |
| 2004 | 0.07x | CN¥60.69 Million | CN¥828.09 Million | ▼ -47.2% |
| 2003 | 0.14x | CN¥71.65 Million | CN¥516.46 Million | ▼ -56.1% |
| 2002 | 0.32x | CN¥127.49 Million | CN¥403.72 Million | ▲ +881.2% |
| 2001 | 0.03x | CN¥14.79 Million | CN¥459.59 Million | ▼ -72.2% |
| 2000 | 0.12x | CN¥61.85 Million | CN¥534.74 Million | ▼ -42.9% |
| 1999 | 0.20x | CN¥58.21 Million | CN¥287.56 Million | ▲ +19.4% |
| 1998 | 0.17x | CN¥41.00 Million | CN¥241.76 Million | — |